Theraclone Sciences' I-STARa Technolo...

Theraclone Sciences' I-STARa Technology Chosen by Wellcome...

Apr 30, 2015 Read more: Freshnews

Theraclone Sciences, Inc., a therapeutic antibody discovery and development company, today announced that it will identify potential therapeutic antibodies against the Ebola virus utilizing the Company's powerful human memory B-cell interrogation platform. The I-STARTM technology can rapidly screen antibodies from survivors of Ebola to uncover those with exceptional biologic activity that may lead to the development of a therapeutic antibody.

Start the conversation, or Read more at Freshnews.

Add your comments below

Characters left: 4000

Please note by submitting this form you acknowledge that you have read the Terms of Service and the comment you are posting is in compliance with such terms. Be polite. Inappropriate posts may be removed by the moderator. Send us your feedback.

Theraclone Sciences Discussions

Title Updated Last By Comments
News AIDS researchers isolate new potent and broadly... (Aug '11) Aug '11 FBOMBER 1